Spots Global Cancer Trial Database for The STAR™ Tumor Ablation Registry
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: The STAR™ Tumor Ablation Registry
Official Title: The STAR™ Tumor Ablation Registry
Study ID: NCT02419703
Conditions
Interventions
Study Description
Brief Summary: Registry collecting data on use of The STAR™ Tumor Ablation System.
Detailed Description: The STAR Prospective Registry is an observational registry to gather clinical safety and outcome data in patients with painful spinal metastases in the thoracolumbar spine (T1-L5) following targeted radiofrequency ablation (t-RFA) treatment with the STAR™ Tumor Ablation System.
Keywords
Eligibility
Minimum Age: 22 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
John Muir Medical Center, Concord, California, United States
Southern California Institute of Neurological Surgery, Escondido, California, United States
University of California, Los Angeles, Los Angeles, California, United States
St. Joseph's Medical Center, Stockton, California, United States
University of Colorado, Denver, Colorado, United States
Mori Bean and Brook Radiology, Jacksonville, Florida, United States
Medical Imaging & Therapeutics, Lady Lake, Florida, United States
VIR Chicago, Chicago, Illinois, United States
University of Kansas Medical Center, Kansas City, Kansas, United States
Mayo Clinic, Rochester, Minnesota, United States
Washington University, St. Louis, Missouri, United States
Wake Forest Health Sciences, Winston-Salem, North Carolina, United States
University of Tennessee, Knoxville, Tennessee, United States
Providence Sacred Heart Medical Center, Spokane, Washington, United States
Medical College of Wisconsin, Milwaukee, Wisconsin, United States
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
